October 31, 2025
Implantable Bioresorbable Scaffold with FCS: The Future of Hematopoietic Therapy
On August 28, 2025, Anisimova et al. published an article in Marine Drugs, titled "Implantable Bioresorbable Scaffold with Fucosylated Chondroitin Sulfate as a Promising Device for Delayed Stimulation of Hematopoiesis". The research validates a novel method for sustained hematopoietic support. The central innovation involves incorporating Fucosylated Chondroitin Sulfate (FCS), a potent glycosaminoglycan derived from marine […]
Read More >